Works matching IS 1021335X AND DT 2024 AND VI 51 AND IP 1
Results: 17
Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS.
- Published in:
- Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8676
- By:
- Publication type:
- Article
The advance of the third‑generation EGFR‑TKI in the treatment of non‑small cell lung cancer (Review).
- Published in:
- Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8675
- By:
- Publication type:
- Article
Oncogenic role of FOXM1 in human prostate cancer (Review).
- Published in:
- Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8674
- By:
- Publication type:
- Article
SYNPO2 promotes the development of BLCA by upregulating the infiltration of resting mast cells and increasing the resistance to immunotherapy.
- Published in:
- Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8673
- By:
- Publication type:
- Article
[Retracted] circNSUN2 promotes the malignant biological behavior of colorectal cancer cells via the miR‑181a‑5p/ROCK2 axis.
- Published in:
- Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8672
- By:
- Publication type:
- Article
Celastrol enhances TRAIL‑R2‑mediated apoptosis and cytotoxicity in human renal cell carcinoma cells in caspase‑dependent manner.
- Published in:
- Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8671
- By:
- Publication type:
- Article
RPF2 mediates the CARM1‑MYCN axis to promote chemotherapy resistance in colorectal cancer cells.
- Published in:
- Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8670
- By:
- Publication type:
- Article
[Rectacted] miR‑106b‑5p promotes cell cycle progression of malignant melanoma by targeting PTEN.
- Published in:
- Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8669
- By:
- Publication type:
- Article
β‑carotene attenuates muscle wasting in cancer cachexia by regulating myogenesis and muscle atrophy.
- Published in:
- Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8668
- By:
- Publication type:
- Article
Copy number variations in esophageal squamous cell carcinoma: Emerging cancer drivers and biomarkers (Review).
- Published in:
- Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8667
- By:
- Publication type:
- Article
Multidrug resistance protein 5 affects cell proliferation, migration and gemcitabine sensitivity in pancreatic cancer MIA Paca‑2 and PANC‑1 cells.
- Published in:
- Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8666
- By:
- Publication type:
- Article
Regulation of Drp1 and enhancement of mitochondrial fission by the deubiquitinating enzyme PSMD14 facilitates the proliferation of bladder cancer cells.
- Published in:
- Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8665
- By:
- Publication type:
- Article
U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review).
- Published in:
- Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8664
- By:
- Publication type:
- Article
[Retracted] miR‑216b inhibits glioma cell migration and invasion through suppression of FoxM1.
- Published in:
- Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8663
- By:
- Publication type:
- Article
Unravelling heterogeneous effects of cancer‑associated fibroblasts on poor prognosis markers in breast cancer EM‑G3 cell line: In vitro‑targeted treatment (anti‑IL-6, anti‑VEGF-A, anti‑MFGE8) based on transcriptomic profiling
- Published in:
- Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8662
- By:
- Publication type:
- Article
MicroRNA‑606 inhibits the growth and metastasis of triple‑negative breast cancer by targeting Stanniocalcin 1.
- Published in:
- Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8661
- By:
- Publication type:
- Article
[Retracted] microRNA‑196b promotes cell migration and invasion by targeting FOXP2 in hepatocellular carcinoma.
- Published in:
- Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8660
- By:
- Publication type:
- Article